Device Trial Radar · NCT05834452
Treatment of Posterior Benign Paroxysmal Positional Vertigo With Mechanical Rotational Chair.
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Apr 12, 2023
Primary completion
Aug 9, 2025
Study completion Jan 9, 2026
Sponsor
- Lead sponsor
- Aalborg University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 28, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Comparison of treatment efficacy of Epley maneuver and 360 maneuver in a mechanical rotational chair (TRV chair) in patient with posterior benign paroxysmal positional vertigo (BPPV).
Conditions
- Benign Paroxysmal Positional Vertigo
- BPPV
Interventions
The Epley ManeuverProcedure
5 step procedure where the patient: 1. Sits upright in a neutral position 2. Rotate 45° towards the affected side around the yaw axis and then ro-tate 135° backward around the pitch axis 3. Rotated 90° towards the unaffected side around the yaw axis 4. Rotate a further 90° toward the unaffected side around the yaw axis 5. Rotates back to an upright position with a 135° backward rotation around the pitch axis.
The 360 Degree ManeuverProcedure
5 step procedure where the patient: 1. Sits upright in a neutral position 2. Rotate 45° towards the affected side around the yaw axis and then ro-tate 135° backward around the pitch axis 3. Rotate a further 90° backward around the pitch axis (total 225°) 4. Rotate a further 90° backward around the pitch axis (total 315°) 5. Rotate back to an upright position with an additional 45° backward rota-tion around the pitch axis (total 360°).
Mechanical rotational chairDevice
TRV chair
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment success after first treatmentTime frame: 2 year
- Number of treatmentsTime frame: 2 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
epartment of Otolaryngology, Head & Neck Surgery and Audiology, Aalborg University Hospital
Aalborg, North Denmark, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.